MEDICAL RESEARCH AND YNHH
Adopting new diet and exercise routines may improve breast cancer remission, Yale researchers find

A team at the Yale Cancer Center found that breast cancer patients undergoing chemotherapy who followed new diet and exercise routines had higher rates of cancer remission.

Yale New Haven Health system hosts annual Closer to Free Ride in support of cancer research and treatment

Thousands participated in the 13th annual Closer to Free Ride in New Haven and around the globe.

Yale experts discuss impact of Medicare price-negotiation legislation

Following the announcement of the 10 drugs for which Medicare is authorized to negotiate prices, Yale experts in healthcare shared their thoughts.

Yale researchers investigate the future of AI in healthcare

While new Yale research shows promising uses for artificial intelligence in healthcare, questions remain.

AI helps predict adverse outcomes in cardiovascular medicine, Yale study finds

Yale researchers have created a noise-adapted artificial intelligence model that can detect heart disease.

Yale researchers receive $4 million from National Institute of Mental Health to advance LGBTQ+-affirming mental health care

A team from the Yale School of Public Health will use the grant to offer their evidence-based therapeutic tools to community centers across the country.

Research team secures $25 million grant to develop mRNA cancer vaccine

The joint team of researchers is looking to use the grant money to revolutionize cancer defense by orchestrating immune responses through mRNA technology.

Long-term exposure to COVID-19 associated with reduced vaccine efficacy, Yale researchers find

A study led by the Yale School of Public Health and Yale School of Medicine, in collaboration with the Connecticut Department of Correction, found that high levels of exposure to the virus are negatively associated with vaccination efficacy and naturally acquired immunity.

YSPH study finds adverse reactions to opioid use disorder medication buprenorphine unlikely

In a study looking at the effects of buprenorphine in 1,200 patients with substance use disorders, the odds of precipitated withdrawal — an adverse reaction caused by medications used to treat opioid dependence — was less than one percent.

YSPH and YPL launch Laboratory-in-a-Van program

A new initiative from the Yale School of Public Health and Yale Pathology Labs hopes to make health screening more accessible through a retrofitted mobile lab.

Yale researchers uncover novel implications of arachnoid cysts

Using an integrated multiomics approach, a recent Yale-led study found that arachnoid cysts may serve as radiographic biomarkers for neuropathologies.